Skip to main content
Erschienen in: European Journal of Epidemiology 5/2009

01.05.2009 | Cardiovascular disease

Gender aspects on heart failure incidence and mortality in a middle-aged, urban, community-based population sample: the Malmö preventive project

verfasst von: G. Tasevska-Dinevska, L. M. A. Kennedy, P. M. Nilsson, R. Willenheimer

Erschienen in: European Journal of Epidemiology | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

There is little epidemiological data on heart failure (HF) in the younger age groups dominating clinical HF trials. We assessed gender-specific long-term HF incidence and mortality in an urban community-based sample of middle-aged subjects. Between 1974 and 1992, 33,342 HF-free subjects (10,900 [32.7%] women, mean age 45.7 ± 7.4 years) were included in the Malmö Preventive Project, on average 21.7 ± 4.3 years before study end. Patients hospitalised for or dying of HF were categorised as HF patients, and 120 (1.1%) women versus 644 (2.9%) men experienced HF: 6.0 vs. 12.3 cases per 10,000 person years; hazard ratio [HR] 0.61, 95% confidence interval [CI] 0.50–0.74, P < 0.0001. Among all subjects, women compared with men had lower all-cause (49.3 vs. 84.0 cases per 10,000 person years; HR 0.68, 95% CI 0.64–0.73, P < 0.0001) and HF-related (2.6 vs. 7.4 cases per 10,000 person years; HR 0.50, 95% CI 0.37–0.67, P < 0.0001) mortality risk. Female and male HF patients had similar age-adjusted mortality risk: 1,314 vs. 1,602 cases per 10,000 patient years; HR 0.78, 95% CI 0.58–1.07, P = 0.12. Among HF patients, 55.3% of deaths in women and 40.6% in men were non-cardiovascular, and only 7.9% deaths were due to HF. In conclusion: In a middle-aged, urban, community-based sample, women had lower risk of HF, all-cause death and HF-related death over two decades of follow-up. Female and male HF patients had similar mortality risk after the diagnosis of HF. In these comparatively young HF patients, few deaths were due to HF and more than 4 out of 10 deaths were non -cardiovascular.
Literatur
1.
Zurück zum Zitat Schocken DD, Arrietta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992;20:301–6.PubMed Schocken DD, Arrietta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992;20:301–6.PubMed
2.
Zurück zum Zitat Petrie MC, Dawson NF, Murdoch DR, Davie AP, McMurray JJV. Failure of women’s hearts. Circulation. 1999;99:2334–41.PubMed Petrie MC, Dawson NF, Murdoch DR, Davie AP, McMurray JJV. Failure of women’s hearts. Circulation. 1999;99:2334–41.PubMed
3.
Zurück zum Zitat Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993;22:6A–13A.PubMed Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993;22:6A–13A.PubMed
8.
Zurück zum Zitat Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in the Framingham Heart Study. Circulation. 1993;88:107–15.PubMed Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in the Framingham Heart Study. Circulation. 1993;88:107–15.PubMed
9.
Zurück zum Zitat Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P, on behalf of the CIBIS II Investigators. Sex differences in the prognosis of congestive heart failure, Results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation. 2001;103:375–80.PubMed Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P, on behalf of the CIBIS II Investigators. Sex differences in the prognosis of congestive heart failure, Results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation. 2001;103:375–80.PubMed
10.
Zurück zum Zitat Lenzen MJ, Rosengren A, Scholte op Reimer WJS, Follath F, Boersma E, Simoons ML, et al. Management of patients with heart failure in clinical practice: differences between men and women. Heart. 2008;94:e10–78. doi:10.1136/hrt.2006.099523.PubMedCrossRef Lenzen MJ, Rosengren A, Scholte op Reimer WJS, Follath F, Boersma E, Simoons ML, et al. Management of patients with heart failure in clinical practice: differences between men and women. Heart. 2008;94:e10–78. doi:10.​1136/​hrt.​2006.​099523.PubMedCrossRef
14.
Zurück zum Zitat SOLVD The investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left-ventricular ejection fractions. N Engl J Med. 1992;327:685–91.CrossRef SOLVD The investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left-ventricular ejection fractions. N Engl J Med. 1992;327:685–91.CrossRef
15.
Zurück zum Zitat CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–35. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–35.
16.
Zurück zum Zitat Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and and ventricular enlargement trial. The SAVE investigators. N Engl J Med. 1992;327:669–77.PubMed Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and and ventricular enlargement trial. The SAVE investigators. N Engl J Med. 1992;327:669–77.PubMed
17.
Zurück zum Zitat Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 1999;100:2312–8.PubMed Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 1999;100:2312–8.PubMed
19.
23.
Zurück zum Zitat Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355:1582–7. doi:10.1016/S0140-6736(00)02213-3.PubMedCrossRef Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355:1582–7. doi:10.​1016/​S0140-6736(00)02213-3.PubMedCrossRef
25.
Zurück zum Zitat Gustafsson F, Torp-Pedersen C, Burchart H, Buch P, Seibaek M, Kjoller E, et al. Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure. Eur Heart J. 2004;25:129–35. doi:10.1016/j.ehj.2003.10.003.PubMedCrossRef Gustafsson F, Torp-Pedersen C, Burchart H, Buch P, Seibaek M, Kjoller E, et al. Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure. Eur Heart J. 2004;25:129–35. doi:10.​1016/​j.​ehj.​2003.​10.​003.PubMedCrossRef
26.
28.
Zurück zum Zitat European Society of Cardiology, Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task Force for the diagnosis and treatment of Chronic Heart Failure. Eur Heart J. 2001;22:1527–60. doi:10.1053/euhj.2001.2783.PubMedCrossRef European Society of Cardiology, Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task Force for the diagnosis and treatment of Chronic Heart Failure. Eur Heart J. 2001;22:1527–60. doi:10.​1053/​euhj.​2001.​2783.PubMedCrossRef
29.
Zurück zum Zitat Tasevska-Dinevska G, Kennedy LM, Anevski D, Nilsson P, Christensson A, Willenheimer R. Gender differences in predictors of heart failure morbidity and mortality in an urban Swedish population: the Malmö preventive project. Open Heart Fail J. 2008;1:1–8. doi:10.2174/1876535100801010001.CrossRef Tasevska-Dinevska G, Kennedy LM, Anevski D, Nilsson P, Christensson A, Willenheimer R. Gender differences in predictors of heart failure morbidity and mortality in an urban Swedish population: the Malmö preventive project. Open Heart Fail J. 2008;1:1–8. doi:10.​2174/​1876535100801010​001.CrossRef
32.
Zurück zum Zitat Fraizer CG, Alexander KP, Newby LK, Anderson S, Iverson E, Packer M, et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction. A pooled analysis of 5 randomized control trials. J Am Coll Cardiol. 2007;49:1450–8. doi:10.1016/j.jacc.2006.11.041.CrossRef Fraizer CG, Alexander KP, Newby LK, Anderson S, Iverson E, Packer M, et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction. A pooled analysis of 5 randomized control trials. J Am Coll Cardiol. 2007;49:1450–8. doi:10.​1016/​j.​jacc.​2006.​11.​041.CrossRef
Metadaten
Titel
Gender aspects on heart failure incidence and mortality in a middle-aged, urban, community-based population sample: the Malmö preventive project
verfasst von
G. Tasevska-Dinevska
L. M. A. Kennedy
P. M. Nilsson
R. Willenheimer
Publikationsdatum
01.05.2009
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 5/2009
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-009-9320-4

Weitere Artikel der Ausgabe 5/2009

European Journal of Epidemiology 5/2009 Zur Ausgabe